Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy

The Discovery of Biomarkers in Cancer Immunotherapy - Computational and Structural Biotechnology Journal

Gut microbiota reshapes cancer immunotherapy efficacy: Mechanisms and therapeutic strategies - Xie - iMeta - Wiley Online Library

Mechanisms of Resistance and Treatment of Relapse after CAR T-cell Therapy for Large B-cell Lymphoma and Multiple Myeloma - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and

Gut microbiome correlates of response and toxicity following anti CD19 CAR T cell therapy

Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy

A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy

Author Correction: Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy

Modulation of the gut microbiota engages antigen cross-presentation to enhance antitumor effects of CAR T cell immunotherapy - ScienceDirect

Potential links between the microbiota and T cell immunity determine the tumor cell fate

IJMS, Free Full-Text

Modulation of the gut microbiota engages antigen cross-presentation to enhance antitumor effects of CAR T cell immunotherapy: Molecular Therapy

Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications